| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/14/2004 | CN1511545A Chinese medicine for treating city plague |
| 07/14/2004 | CN1511542A Composition for improving obstacle under pharynx |
| 07/14/2004 | CN1511540A Use of scutellarin in preparing medicine for treating or preventing stomatocace |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/14/2004 | CN1157371C Monohydrate of cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexancecarboxylate |
| 07/14/2004 | CN1157225C Lectin compositions and uses tehreof |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157221C Health compsn. |
| 07/14/2004 | CN1157220C Medicine for treating intestinal disease |
| 07/14/2004 | CN1157209C Medicinal composition containing aloe and its application |
| 07/14/2004 | CN1157207C Chinese medicine with physique enhancing and disease treating functions and its producing process |
| 07/14/2004 | CN1157196C Galenic preparation for prevetion and treatment of hepatocarcinoma |
| 07/14/2004 | CN1157194C Method for processing freeze-dried deer blood |
| 07/14/2004 | CN1157192C Pharmaceutical application of crust holoside and derivant thereof |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762191 Therapeutic compounds |
| 07/13/2004 | US6762189 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6762021 Method for diagnosis of crohn's disease |
| 07/13/2004 | US6761879 Titanium derived compounds, preparation and use thereof |
| 07/13/2004 | CA2288913C Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2259270C Pharmaceutical preparation containing nimesulide for oral administration |
| 07/13/2004 | CA2238040C Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 07/13/2004 | CA2158354C Use of granisetron for the treatment of post-operative nausea and vomiting |
| 07/08/2004 | WO2004056862A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | WO2004056831A1 PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION |
| 07/08/2004 | WO2004056810A1 Xanthine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056809A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056808A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056804A2 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 07/08/2004 | WO2004056773A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056381A1 Antiulcer herbal composition(s) |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004011621A3 Multi-step method for the differentiation of insulin positive, glucose |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2004001023A3 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003072061A3 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003024965A3 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040132984 Oligonuclelotide sequences for use in controlling expression and translation of neutrophil gelatinase associated lipocalin (NGAL) and treatment and prevention of inflammatory bowel disease: RNA interference; gene expression inhibition |
| 07/08/2004 | US20040132824 Novel methods and compositions for alleviating pain |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132815 sulfodehydroabietic acid or a salt thereof; may be administered as a gargle, a liniment, a patch, a spray, a troche or a buccal preparation. |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132797 treating of or preventing relapse of depression, anxiety disorders, eating disorders, or urinary incontinence |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132768 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132693 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132641 Fas peptide mimetics and uses thereof |
| 07/08/2004 | US20040132636 Pharmaceutical uses for alpha2delta ligands |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132057 Tumor necrosis related receptor,TR7 |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131702 Mixture with acid |
| 07/08/2004 | US20040131698 Methods of treating conditions using metal-containing materials |
| 07/08/2004 | US20040131689 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 07/08/2004 | US20040131677 Absorption; side effect reduction; encapsulation in polyvinylpyrrolidone; bioavailability |
| 07/08/2004 | US20040131608 Antibodies; suppression, therapy, prevention |
| 07/08/2004 | US20040131583 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/08/2004 | US20040129112 Metal-containing materials |
| 07/08/2004 | DE19751907B4 Verwendung von Escherichia coli Stamm DSM 6601 zur Behandlung von Diarrhoeen auf dem Veterinärsektor Escherichia coli strain DSM 6601 for the treatment of diarrhea in the veterinary sector |
| 07/08/2004 | CA2511726A1 Xanthine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | CA2510849A1 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 07/08/2004 | CA2508624A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | CA2507637A1 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1434990A2 Method for identifying compounds the specifically deplete mast cells |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434799A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434786A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |